Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8858876 | 0.91 | AGTR1 (0.76) | AGTR1AGTR2 | |
| SCHEMBL7706063 | 0.90 | AGTR1 (0.69) | AGTR1AGTR2 | |
| SCHEMBL7706792 | 0.90 | AGTR1 (0.67) | AGTR1AGTR2 | |
| SCHEMBL8823602 | 0.89 | AGTR1 (0.67) | AGTR1AGTR2 | |
| SCHEMBL8823621 | 0.88 | AGTR1 (0.65) | AGTR1AGTR2 | |
| SCHEMBL7706142 | 0.87 | AGTR1 (0.61) | AGTR1AGTR2 | |
| SCHEMBL9873124 | 0.86 | AGTR2 (0.62) | AGTR1AGTR2 | |
| SCHEMBL8823513 | 0.86 | AGTR1 (0.62) | AGTR1AGTR2 | |
| SCHEMBL708 | 0.85 | AGTR1 (0.80) | AGTR1AGTR2 | |
| SCHEMBL8823537 | 0.85 | AGTR1 (0.66) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0644188-B1 | Process for the preparation of sulfur derivatives of imidazole and intermediates obtained | AVENTIS PHARMA SA (FR) | 2002-12-04 | — | — | EP | claimed |
| EP-0648763-B1 | Process for the preparation of sulfur derivatives of imidazole and intermediates obtained | AVENTIS PHARMA SA (FR) | 2001-05-09 | — | — | EP | claimed |
| EP-0465368-B1 | Sulfur derivatives of imidazole, process for their preparation, intermediates, their use as medicaments, and pharmaceutical compositions containing them | HOECHST MARION ROUSSEL INC (FR) | 1998-05-20 | — | — | EP | claimed |
| US-5599830-A | ANGIOTENSIN INHIBITORS | ROUSSEL UCLAF (FR) | 1997-02-04 | — | — | US | claimed |
| US-5412101-A | Angiotensin II inhibitor | ROUSSEL-UCLAF (FR) | 1995-05-02 | — | — | US | claimed |
| JP-4230369-A | — | — | None | — | — | JP | disclosed |
| JP-7215945-A | — | — | None | — | — | JP | disclosed |
| US-5684028-A | ANGIOTENSIN II INHIBITORS | ROUSSEL UCLAF (FR) | 1997-11-04 | — | — | US | disclosed |
| US-5599830-A | ANGIOTENSIN INHIBITORS | ROUSSEL UCLAF (FR) | 1997-02-04 | — | — | US | disclosed |
| US-5527919-A | Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids | ROUSSEL UCLAF (FR) | 1996-06-18 | — | — | US | disclosed |
| JP-H07215945-A | NOVEL PROCESS FOR PRODUCTION OF SULFATED DERIVATIVE OF IMIDAZOLE AND OBTAINED NOVEL INTERMEDIATE | ROUSSEL UCLAF | 1995-08-15 | — | — | JP | disclosed |
| US-5412101-A | Angiotensin II inhibitor | ROUSSEL-UCLAF (FR) | 1995-05-02 | — | — | US | disclosed |
| JP-H04230369-A | NEW SULFUR DERIVATIVE OF IMIDAZOL AND ITS PRODUCTION, OBTAINED NEW INTERMEDIATE, ITS USE AS DRUG, AND MEDICINAL COMPOSITION CONTAINING THE SAME | ROUSSEL UCLAF | 1992-08-19 | — | — | JP | disclosed |